U.S. Electrical Stock News

NYSE:DLB
NYSE:DLBSoftware

Does Dolby (DLB) Supercharged Buyback Plan Reframe Its Long‑Term Risk and Capital Allocation Story?

In late July 2026, Dolby Laboratories reported third‑quarter results showing revenue of US$305 million and net income of US$28.6 million, alongside new fourth‑quarter and full‑year 2026 guidance, a US$0.36 dividend, and an expanded share repurchase authorization to US$3.65 billion. Although quarterly profit eased year on year, Dolby’s decision to raise its buyback capacity and maintain dividends underscores management’s emphasis on returning cash to shareholders while its licensing programs...
NYSE:WH
NYSE:WHHospitality

Does Stronger Margins And Upgraded 2026 Outlook Change The Bull Case For Wyndham Hotels & Resorts (WH)?

In July 2026, Wyndham Hotels & Resorts reported second-quarter revenue of US$375 million, down from US$397 million a year earlier, while net income increased to US$102 million and diluted earnings per share from continuing operations rose to US$1.36 from US$1.13. Alongside higher earnings, the company raised its full-year 2026 net revenue and global RevPAR outlook and continued its multi-year share repurchase program, signaling confidence in its business model and cash generation. Now we’ll...
NasdaqGS:XRX
NasdaqGS:XRXTech

Xerox (XRX) Is Up 14.3% After Raising 2026 Guidance And Lexmark Synergy Targets – What's Changed

In July 2026, Xerox Holdings Corporation reported second-quarter results showing revenue of US$1,922 million and net income of US$13 million, alongside a smaller six-month net loss and higher year-to-date revenue versus the prior year. The company also raised its full-year 2026 guidance to approximately US$7.60 billion in revenue and increased synergy targets from its Lexmark collaboration, highlighting progress on priorities to stabilize revenue, improve profitability, and reduce...
NYSE:BTU
NYSE:BTUOil and Gas

Peabody Energy (BTU) Reports Sales Growth And A Net Loss, Is The Stock Still Undervalued?

Peabody Energy (BTU) has drawn fresh attention after second quarter results on July 29 showed higher sales and a shift to a net loss, along with a dividend affirmation and an update on its ongoing share repurchase program. See our latest analysis for Peabody Energy. The earnings release appears to have cooled short term sentiment around Peabody Energy, with the share price down 6.5% over the past week and 30.5% year to date, although the 1 year total shareholder return of 34.3% and 5 year...
NasdaqGS:CORZ
NasdaqGS:CORZSoftware

Is Core Scientific (CORZ) A Bargain After Its AMD AI Infrastructure Deal?

Core Scientific (CORZ) is back in focus after announcing a long-term AI infrastructure agreement with AMD that targets up to 2.5 gigawatts of data center capacity and a 15-year high performance computing colocation deal. See our latest analysis for Core Scientific. The AMD agreement comes as Core Scientific’s share price has eased in the short term, with a 1-day share price return of 5.0% lower and a 7-day return of 8.92% lower. However, the year-to-date share price return of 29.58% and...
NYSE:BDX
NYSE:BDXMedical Equipment

Is BD (BDX) Quietly Building a GLP-1 Delivery Moat With Its Brazil Semaglutide Partnership?

BD (Becton, Dickinson and Company) and EMS previously announced a collaboration to launch a semaglutide therapy in Brazil, using BD’s Vystra Injection Pen platform designed for ease of use in treating chronic conditions such as obesity and type 2 diabetes. This partnership highlights how BD’s drug delivery expertise is being applied to support rising demand for injectable GLP-1 therapies in a major emerging healthcare market. Next, we’ll examine how BD’s role in semaglutide delivery through...
NasdaqGS:INCY
NasdaqGS:INCYBiotechs

The Bull Case For Incyte (INCY) Could Change Following New EU Opzelura Atopic Dermatitis Approval

In late July 2026, the European Commission approved Incyte’s Opzelura (ruxolitinib) cream for adults with moderate atopic dermatitis whose disease is inadequately controlled by, or unsuitable for, topical corticosteroids and calcineurin inhibitors, following supportive Phase 3b TRuE-AD4 data showing significant symptom improvement and a favorable 24-week safety profile. This second European indication for Opzelura, alongside its existing approval in non-segmental vitiligo, deepens Incyte’s...
NYSE:OC
NYSE:OCBuilding

Owens Corning (OC) Could Be 5% Undervalued As New Leadership Takes Shape

Owens Corning (OC) is back in focus after announcing a reshaped leadership team, with Jonathan Collins set to become Chief Financial Officer and Executive Vice President, and Todd W. Fister promoted to President and Chief Operating Officer. See our latest analysis for Owens Corning. Owens Corning’s latest leadership changes land at a time when the stock is trading at US$138.90, with a 90 day share price return of 13.18% and a more muted 1 year total shareholder return of 4.30%. This suggests...
NYSE:SSB
NYSE:SSBBanks

SouthState Bank (SSB) Stock Looks Cheap, But Can Margins Hold

SouthState Bank stock barely flinched after earnings. The share price ticked down around 0.2% to about US$105, even as the quarterly report put a different story on the table. Return on tangible common equity of 17.6% and net profit margins of 35.5% over the last twelve months speak to a bank still producing solid profitability while trading on a P/E of roughly 10.7x and at a sizeable gap to one discounted cash flow estimate of fair value. For investors thinking beyond this week’s tiny move,...
NYSE:ABBV
NYSE:ABBVBiotechs

AbbVie (ABBV) Stock Faces A Pivotal Growth Handoff After Guidance Lift

AbbVie stock slipped about 2.5% today and is roughly flat over the past month, even after a strong second quarter that pushed adjusted earnings per share to $3.65 and revenue to nearly $17.0b. The market is reacting to the near term. The numbers are pointing you to a longer story. The headline is simple. AbbVie just delivered double digit revenue growth in a period when investors are still focused on legacy patent risks and a very rich trailing P/E of about 123x. The real question now is how...
NYSE:AAP
NYSE:AAPSpecialty Retail

Advance Auto Parts (AAP) Stock Looks Reasonable On Cash Flow But Rich On Earnings

Advance Auto Parts stock is coming off a long weak stretch, with a sharply negative five year return, while the current valuation checks still suggest the shares are not a clear bargain. After a solid rebound this year, investors now face a stock that screens as expensive on broad metrics rather than obviously cheap after the pullback. Over the past five years, Advance Auto Parts has delivered a return of about 69.5% in decline, which puts extra focus on whether the recent recovery leaves...
NYSE:JBL
NYSE:JBLElectronic

Jabil (JBL) Stock Still Looks Reasonable As Its 437% Run Continues

Jabil stock has delivered a very large 5 year return, yet at around US$315 per share the intrinsic value estimate based on a Discounted Cash Flow (DCF) model and the market multiples both still point to the shares screening as undervalued. Jabil has returned 436.5% over the past 5 years, which puts extra focus on whether the current price still offers a margin between market value and intrinsic value. The key support for the current valuation is the market's view of Jabil's ability to keep...
NYSE:WT
NYSE:WTCapital Markets

WisdomTree (WT) Stock Rises On 42.6% Margin As Valuation Questions Persist

WisdomTree stock came into this earnings season with a strong run, up double digits over the past quarter, yet the immediate reaction after the release was a measured 3% gain. That move understates how striking the profit picture looked. Adjusted operating margin landed above 40% and Q2 revenue reached US$177.2m. For an asset manager, that margin profile is the headline. It signals a business increasingly turning record assets under management and healthy flows into earnings power, even as...
NYSE:OPY
NYSE:OPYCapital Markets

Oppenheimer Holdings (OPY) Stock Drops As Quarterly Loss Clouds Value Case

Oppenheimer Holdings walked into this earnings season with a value label, trading on a trailing P/E of 11.8x against a far richer US capital markets peer group. The stock still slipped 3.7% to US$106.64 on the first trading day after results, as investors focused on a sharp swing from recent profits to a quarterly loss of US$20.6 million and basic earnings per share of US$1.93 in the red. The headline is simple: a firm that had reported strong recent earnings growth just printed a loss, and...
NYSE:RBLX
NYSE:RBLXEntertainment

Roblox (RBLX) Guidance Reset Puts Its Valuation Story Under Pressure

Roblox (RBLX) is back in focus after its latest earnings update and guidance reset triggered a sharp one day drop in the stock. Investors are reassessing how recent platform changes might affect future monetisation. See our latest analysis for Roblox. The sharp one day share price drop after Roblox updated guidance sits on top of already weak momentum, with the 1 day share price return down 26.85% and the year to date share price return down 56.02%. Over a longer horizon, the 1 year total...
NYSE:NVT
NYSE:NVTElectrical

nVent (NVT) Stock Rallies As AI Demand Lifts Guidance

The market loved nVent Electric’s latest quarter. The stock jumped 6.2% to US$153.83, even though it had been flat over the past week and slightly down over the past month and quarter. That is a sentiment reset in a single session. The spark was not a soft beat. nVent Electric delivered record Q2 sales of US$1.471b and adjusted earnings per share of US$1.45, with management lifting full year revenue and earnings guidance. Investors are treating this as confirmation that the data center and...
NasdaqGS:VTRS
NasdaqGS:VTRSPharmaceuticals

Viatris (VTRS) Stock May Be Cheap Following Its 107% 1 Year Run

Viatris stock has delivered a strong 1 year run, yet its valuation checks still suggest the shares may be pricing in less optimism than that performance might imply. The stock has returned 107.2% over the past year, which puts recent enthusiasm front and center for anyone assessing what is already priced in. The recent U.S. FDA approval of the once weekly Gwyn Lo contraceptive patch can support sentiment around future revenue potential, while any execution issues in bringing new products to...
NasdaqGS:SGRY
NasdaqGS:SGRYHealthcare

Is Surgery Partners (SGRY) Fully Valued On Reaffirmed 2026 Guidance?

Surgery Partners (SGRY) recently reaffirmed its 2026 earnings guidance, telling investors to expect revenues between US$3.35b and US$3.45b. This keeps attention on how the company balances this outlook with ongoing operational challenges. See our latest analysis for Surgery Partners. Despite reaffirmed guidance, Surgery Partners’ recent trading tells a mixed story. The stock has fallen about 7% on a 30 day share price return basis but is still up nearly 8% over 90 days. The 1 year total...
NasdaqGS:MSTR
NasdaqGS:MSTRSoftware

Strategy (MSTR) Stock Trades At A Discount To Book Value Yet Broader Checks Stay Weak

Strategy stock has fallen sharply over the past year yet still shows a very strong 3 year return, and the company now screens as undervalued on market multiples while carrying a low overall value score. With fresh headlines focused on its Bitcoin exposure and new valuation metrics, investors are trying to work out whether the recent share price slide has moved Strategy closer to a genuine bargain or just reset expectations. Strategy has returned 147.4% over the past 3 years, which points to...
NasdaqGS:LAMR
NasdaqGS:LAMRSpecialized REITs

Lamar Advertising (LAMR) Has Strong Recent Returns, Is It Fully Priced?

Lamar Advertising (LAMR) has drawn fresh attention after recent share price moves, with the stock closing at US$159.96. Investors are weighing this against the company’s size, business mix and recent return profile. See our latest analysis for Lamar Advertising. While Lamar Advertising’s share price eased 0.43% over the last session to US$159.96, the 90 day share price return of 13.97% and one year total shareholder return of 38.95% indicate momentum has been building over both shorter and...
NYSE:MO
NYSE:MOTobacco

Is Altria (MO) Quietly Rewriting Its Investment Story Around Smoke-Free Growth and Buybacks?

In late July 2026, Altria Group reported second-quarter 2026 results showing sales of US$5,356 million, slightly higher than a year earlier, while net income and earnings per share from continuing operations dipped modestly and the company continued its share repurchase program. Management also modestly raised full-year adjusted earnings guidance on the back of cigarette pricing and growth in smoke-free products, particularly nicotine pouches, while signaling ongoing investment and...
NasdaqGS:STX
NasdaqGS:STXTech

The Bull Case For Seagate Technology Holdings (STX) Could Change Following Strong Q4 Results And Upbeat Guidance

In late July 2026, Seagate Technology Holdings reported fourth-quarter sales of US$3,629 million and net income of US$1,294 million, with full-year revenue reaching US$12.20 billion and earnings of US$3.18 billion, and also declared a quarterly dividend of US$0.74 per share payable in October 2026. The earnings release, combined with revenue guidance of about US$4.10 billion for the first quarter of fiscal 2027, highlighted how stronger profitability and forward visibility are influencing...
NasdaqGS:NWPX
NasdaqGS:NWPXConstruction

NWPX Infrastructure (NWPX) On Strong Q2 Results And Why The Stock Still Looks Fully Valued

NWPX Infrastructure (NWPX) has drawn fresh attention after reporting second quarter 2026 results on 29 July. Revenue reached US$159.48 million and net income was US$15.83 million, with earnings per share higher than a year earlier. See our latest analysis for NWPX Infrastructure. The latest earnings release has come after a strong run in NWPX Infrastructure’s share price, with the stock up 95.27% year to date and delivering a 203.60% total shareholder return over the past year. This comes...
NasdaqGS:LINC
NasdaqGS:LINCConsumer Services

Is Lincoln Educational Services (LINC) Stock Below Fair Value Or Above It?

Lincoln Educational Services stock has delivered very strong gains over the past few years, yet investors now face a split valuation picture where the Discounted Cash Flow (DCF) intrinsic value suggests a sizeable discount to current pricing, while earnings-based multiples point to a richer valuation. Lincoln Educational Services has returned very close to 5x over the past 3 years, which puts extra focus on whether recent gains are fully backed by fundamentals. Expectations for the company...